RxDoctor Payments Data

Mahmoud Loghman-Adham

Pediatric Nephrology · Nutley, NJNPI 1043594120

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $443,152 of the $443,152 with a category attached, or 100.0%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 64.7% of it on its own, with 2 other manufacturers making up the rest.

$443,152in general payments, 2019–2025

Across 80 payments — averaging $5539.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$287K
  • American Regent$155K
  • Daiichi Sankyo Inc.$1K

What the payments were for

  • Consulting fees$443,152100%

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Takeda Pharmaceuticals U.S.A., Inc.41$286,540
American Regent38$155,464
Daiichi Sankyo Inc.1$1,148

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric nephrology providers in New Jerseyto place this figure against a meaningful peer group, so we don't.

Other pediatric nephrology in Nutley

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →